Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CV Sciences ( (CVSI) ) has issued an update.
On June 2, 2025, CV Sciences, Inc. held its 2025 Annual Meeting virtually, with approximately 54.6% of the outstanding shares represented by proxy. During the meeting, stockholders elected three directors, ratified the selection of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, approved the executive officer compensation on a non-binding advisory basis, and decided that the advisory vote on executive compensation should occur every two years.
Spark’s Take on CVSI Stock
According to Spark, TipRanks’ AI Analyst, CVSI is a Underperform.
The overall stock score is primarily impacted by significant financial challenges and weak technical indicators. Although there are positive strategic initiatives and efforts to improve profitability, these are currently overshadowed by declining revenues, operational inefficiencies, and valuation concerns.
To see Spark’s full report on CVSI stock, click here.
More about CV Sciences
Average Trading Volume: 225,075
Technical Sentiment Signal: Sell
Current Market Cap: $4.94M
Find detailed analytics on CVSI stock on TipRanks’ Stock Analysis page.